Price
258.65
+0.19%52W Range
Market Cap
₹312.94 Cr
Traded: ₹0.39 Cr (0.12%) 0.0x
Volume · 60D trend
15 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|
Quarterly Results
Mar 2026
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Mar 2026 | |
|---|---|
| Sales | 112 |
| Expenses | 98 |
| Operating Profit | 14 |
| Other Income | 0 |
| Interest | 1 |
| Depreciation | 0 |
| Profit Before Tax | 13 |
| Tax % | 27.0% |
| Net Profit | 10 |
| Exceptional Items | -- |
| EPS (Rs) | 7.9 |
| Sales Growth (YoY) | 24.4% |
| Sales Growth (QoQ) | 8.7% |
| OP Growth (YoY) | -- |
| OP Growth (QoQ) | -- |
| Profit Growth (YoY) | -- |
| EPS Growth (YoY) | -16.1% |
| EPS Growth (QoQ) | -6.3% |
| OP Margin | 12.5% |
| Net Margin | 8.9% |
| Material Cost % | 83.0% |
| Employee Cost % | 2.0% |
| P/S | 0.75 |
| P/E | 1.84 |
| P/B | 2.41 |
Exchange Filings
50Chemkart India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve 1. Un-Audited Standalone and ....
We are submitting herewith Disclosure for Change in CIN of the Company on Corporate Information Page on BSE Limited.
Disclosure under Regulation 74(5) for Quarter ended 30th September 2026.
We are submitting herewith copy of Voting Results and Scruitinizers Report for 7th Annual General Meeting held on 19th September 2026.
We are submitting herewith Proceedings of 7th AGM held on Saturday, 19th September 2026.
Disclosure under Regulation 30 for Acquisition of Equity Shares of Wholly-Owned Subsidiary Company under the Rights Issue.
Disclosure under Regulation 30 for Appointment of Chief Financial Officer.
Disclosure under Regulation 30 for Resignation of Chief Financial Officer.
Outcome of Board Meeting dated 10th September 2026.
Revised Annual Report 2025-26. (Rectified post Typographical errors).
Copies of Newspaper Publications dated 27th August 2026.
Annual Report for the Financial Year 2025-26.
Notice of 7th AGM to be held on 19th September 2026.
E-Voting Information for 7th AGM.
Copies of Newspaper Publications related to 7th AGM of the Company.
Outcome of Board Meeting dated 18th August 2026.
Appointment of Statutory Auditors for 5 Years subject to Shareholders Approval.
Appointment of Secretarial Auditor for 5 Years subject to Shareholders Approval.
We are submitting Monitoring Agency Report for the Quarter ended 30th June 2026.
Disclosure under Regulation 30 of SEBI LOD Regulations 2015 for Acqusition of Equity Shares in Wholly-Owned Subsidiary Company.
Disclosure under Regulation 74(5) for Quarter ended 30th June 2026.
Copy of Press Release issued by the Company.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jaini Mehta
Pursuant to Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulation, 2015, we are submitting herewith the disclosures received to the Company under Reg 7(2)(a) of PIT Regulations, ....
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shailesh Mehta
Pursuant to Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015, we are submitting herewith the revised disclosures received to the Company under Reg 7(2)(a) of ....
Pursuant to Reg 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015, we are submitting herewith the disclosures received to the Company under Reg 7(2)(a) of PIT Regulations, ....
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shailesh Vinodrai Mehta
Pursuant to Reg 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015, we are submitting herewith the disclosures received to the Company under Reg 7(2)(a) of PIT Regulations, ....
Disclosure under Regulation 30 for Investment in Wholly Owned Subsidiary Company.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jaini Shailesh Mehta
Pursuant to Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015, we are submitting herewith the disclosures received to the Company under Regulation 7(2)(a) of ....
Disclosure of Acquistion of Equity Shares in Wholly Owned Subsidiary Company by way of Rights Issue.
Outcome of Board Meeting dated 18th May 2026.
Investor''s Presentation based on Financial Results for the Half Year and the Financial Year ended 31st March 2026.
Regulation 32 Statement - Half Year ended 31st March 2026.
Financial Results for the Half Year and the Financial Year ended 31st March 2026.
Appointment of Secretarial Auditor for FY 2025-26.
Appointment of Internal Auditor for FY 2026-27.
Monitoring Agency Report for the Quarter ended 31st March 2026.
Chemkart India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 ,inter alia, to consider and approve 1. Audited Standalone and Consolidated ....
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Certificate under Regulation 74(5) for the Quarter ended 31st March 2026.
The Exchange has sought clarification from Chemkart India Ltd on April 9, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
Company''s Clarification on movement in price of Company''s Equity Shares on BSE Limited.
Disclosure as per Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Disclosure as per Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Pursuant to Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015 we are submitting herewith the disclosures received to the Company under Regulation 7(2)(b) of ....
Intimation for Closure of Trading Window w.e.f 01st April 2026.
Disclosure under Regulation 30 for Acquisition of Equity Shares of Wholly Owned Subsidiary Company under Rights Issue.